Advances in cancer research. Volume 58 /
ADVANCES IN CANCER RESEARCH, VOLUME 58.
| Corporate Author: | |
|---|---|
| Other Authors: | , |
| Format: | eBook |
| Language: | English |
| Language Notes: | English. |
| Published: |
San Diego :
Academic Press,
©1992.
|
| Series: | Advances in cancer research ;
v. 58 |
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- Front Cover; Advances in Cancer Research; Copyright Page; Contents; Contributors To Volume 58; Chapter 1. Epstein-Barr Virus in B Lymphocytes: Viral Gene Expression and Function in Latency; I. Natural History of the Virus and Associated Diseases; II. Expression and Function of EBV Genes during Latency; III. Structure of Viral Transcripts and Promoters for the EBV Latent Genes; IV. Perspective on Viral Gene Expression in the LCL Model; References; Chapter 2. The Physiology of Transforming Growth Factor-a; I. Introduction; II. TGF-a Is a Member of a Growth Factor Family
- III. The Structure of TGF-a and Its PrecursorIV. Interactions of TGF-a with the EGF/TGF -a Receptor; V. The Transmembrane TGF-a Precursor; VI. A Role for TGF -a in the Physiology of Normal Cells; VII. TGF-a in Normal Development; VIII. A Role for TGF -a in Tumor Development?; References; Chapter 3. The Role of Raf-1 Phosphorylation in Signal Transduction; I. The raf oncogene Family; II. Raf-1 Activation following Growth Factor Stimulation; III. Sites of Raf-1 Phosphorylation; IV. Consequences of Raf-1 Activation; V. Conclusion; References
- Chapter 4. G Protein-Controlled Signal Transduction Pathways and the Regulation of Cell ProliferationI. Introduction; II. Signal Transduction by Receptors with Ligand Dependent Tyrosine Kinase Activity; III. Signal Transduction through G Protein-Coupled Receptors; IV. Conclusion; References; Chapter 5. Regulation of Muscle Cell Growth and Differentiation by the MyoD Family of Helix...Loop...Helix Proteins; I. Introduction; II. Evidence for Myogenic Regulatory Genes; III. The MyoD Family of Muscle-Specific Regulatory Factors
- IV. Antagonism between Proliferation and Differentiation within the Myogenic LineageV. Summary; References; Chapter 6. Molecular Genetic Characterization of CNS Tumor Oncogenesis; I. Introduction; II. Explanation of Model; III. Comparison of Molecular Genetic and Histopathologic Analysis; IV. Status of Identifying and Characterizing Specific Gene Alterations in CNS Tumor Development; V. Implications of Molecular Genetic Analysis on CNS Tumor Diagnosis and Treatment; References; Chapter 7. Tumor Eradication by Adoptive Transfer of Cytotoxic T Lymphocytes; I. T Cell Immunity
- II. Processing of Antigens for Recognition by T CellsIII. Immunogenicity of Tumors; IV. Adoptive lmmunotherapy of Virus-Induced Tumors with T Cells; V. Escapes of Tumor Cells from Immune T Cells; VI . Relationship of LAK Cells, TIL Cells, NK Cells, and T Cells, All with Antitumor Activity and Clinical Results of Adoptive Therapy with LAK and TIL Cells; VII. Cloned T Cells with Autologous Tumor Specificity in Malignant Melanoma: Nature of the Melanoma Antigens; VIII. Epilogue; References; Chapter 8. Toward a Genetic Analysis of Tumor Rejection Antigens; I. Introduction